title: Unresectable perineal cuniculatum carcinoma: partial remission using systemic isotretinoin and interferon-α2a therapy.
authors.affiliation: Department of Dermatology, University Paris Diderot, Sorbonne Paris Cité,Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris, FR-75475 Paris Cedex 10, France.
authors.forename: Marie
authors.initials: M
authors.lastname: Tauber
authors.forename: Gentiane
authors.initials: G
authors.lastname: Monsel
authors.forename: Lucie
authors.initials: L
authors.lastname: Bonnecarrère
authors.forename: Maxime
authors.initials: M
authors.lastname: Battistella
authors.forename: Nadège
authors.initials: N
authors.lastname: Cordel
authors.forename: Carla
authors.initials: C
authors.lastname: Honein
authors.forename: François
authors.initials: F
authors.lastname: Aubin
authors.forename: Martine
authors.initials: M
authors.lastname: Bagot
authors.forename: Antoine
authors.initials: A
authors.lastname: Petit
authors.forename: Céleste
authors.initials: C
authors.lastname: Lebbé
authors.forename: Manuelle
authors.initials: M
authors.lastname: Viguier
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001005:Anus Neoplasms / Q000188:drug therapy* / Q000473:pathology; D062688:Buschke-Lowenstein Tumor / Q000188:drug therapy* / Q000473:pathology; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000473:pathology; D059248:Chemoradiotherapy; D005834:Genital Neoplasms, Male / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage; D015474:Isotretinoin / Q000008:administration & dosage; D008297:Male; D010502:Perineum / Q000473:pathology*; D011994:Recombinant Proteins / Q000008:administration & dosage; D012074:Remission Induction; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D015474:Isotretinoin